Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
JD Health International, Inc. ( (HK:6618) ) has issued an update.
JD Health International has granted 834,412 new share awards under its Post-IPO Share Award Scheme to group employees, excluding directors and senior management, representing about 0.03% of its issued share capital. The awards, granted at a reference market price of HK$48.64 per share, will vest over periods ranging from a few months to four years.
The company set no performance targets for these awards but implemented robust clawback provisions tied to misconduct, termination circumstances, and any future financial restatements. This move underscores JD Health’s use of equity incentives to retain and motivate staff while protecting corporate and shareholder interests through stringent forfeiture and recovery mechanisms.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$52.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International Inc. is a Hong Kong-listed healthcare platform company incorporated in the Cayman Islands, operating under stock codes 6618 and 86618. It focuses on digital health services and related healthcare offerings within the broader JD.com ecosystem, serving consumers and patients through online medical and health-management solutions.
Average Trading Volume: 8,034,381
Technical Sentiment Signal: Sell
Current Market Cap: HK$151.1B
See more data about 6618 stock on TipRanks’ Stock Analysis page.